In this edition we mark the sad birthday of 5-year-old Ariel Bibas, the little redhead being held by Hamas with his baby brother and parents. We also want you to know about the courageous stand taken by Ayelet Samerano against the UNWRA secretary-general in Lausanne.
Read about how long can a hostage survive in captivity, about Turkey in NATO, the threats to Israel from Iran and Hezbollah and what the IDF says might happen.
When Nvidia paid $6.9 billion in 2020 to acquire Mellanox Technologies, an Israeli specialist in high-speed communications chips, the deal was framed as a strategic complement to its dominant graphics processors. Six years later, that acquisition has become one of the most consequential bets in the company’s history.
The Yokneam, Israel-based company said it had net income of 42 cents per share. Earnings, adjusted for stock option expense, came to 46 cents per share.
Just as NVidia doubles down on Israel (and the Yokneam area in particular), Boston Scientific has decided to move the Galil Medical activity that it acquired to Ireland.
On Friday, NVidia announced a technological breakthrough by their Yokneam R&D center that will allow data centers in geographically distant locations to operate as if they were in one place, effectively creating “AI factories” on a massive scale and significantly increasing the maximum computing power available to the industry.
The patent protects Wearable Devices’ proprietary neural interface technology that enables gesture-based control and real-world physical measurements directly from the wrist.
Yokneam’s largest Hi-Tech company, NVIDIA, is looking for 29 acres to build a new R&D hub that will expand its presence. This major expansion of what began as Mellanox will continue to transform the entire AI industry.
According to a mid-year analysis by Startup Nation Central, roughly $9.3 billion was invested in Israeli hi-tech since the beginning of the year, a 54% jump compared to the second half of 2024.
Clinical data of Cytora's oral mucosa stem cells treatment shown to be safe and may be efficient as a disease modifying therapy in moderate stages of Multiple System Atrophy
Nvidia's development and production centers in Israel will benefit from the huge deal and will be able to sell their wares in Saudi Arabia, even though it has decided not to recognize Israel.
